Healthcare -
Medical - Healthcare Plans - NYSE - US
$ 524.7
-0.0667 %
$ 480 B
Market Cap
33.87
P/E
1. INTRINSIC VALUE
Balance Sheet
UnitedHealth Group Incorporated
| Current Assets | 85.8 B |
| Cash & Short-Term Investments | 29.1 B |
| Receivables | 48.5 B |
| Other Current Assets | 8.21 B |
| Non-Current Assets | 212 B |
| Long-Term Investments | 52.4 B |
| PP&E | 10.6 B |
| Other Non-Current Assets | 150 B |
| Current Liabilities | 104 B |
| Accounts Payable | 68.6 B |
| Short-Term Debt | 4.54 B |
| Other Current Liabilities | 30.7 B |
| Non-Current Liabilities | 91.9 B |
| Long-Term Debt | 72.4 B |
| Other Non-Current Liabilities | 19.6 B |
EFFICIENCY
Earnings Waterfall
UnitedHealth Group Incorporated
| Revenue | 400 B |
| Cost Of Revenue | 311 B |
| Gross Profit | 89.4 B |
| Operating Expenses | 57.1 B |
| Operating Income | 32.3 B |
| Other Expenses | 17 B |
| Net Income | 15.2 B |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
UnitedHealth Group Incorporated
| Net Income | 15.2 B |
| Depreciation & Amortization | 4.1 B |
| Capital Expenditures | -3.5 B |
| Stock-Based Compensation | 1.02 B |
| Change in Working Capital | -808 M |
| Others | 4.14 B |
| Free Cash Flow | 20.7 B |
Wall Street Analysts Price Targets
UnitedHealth Group Incorporated
Wall Street analysts predict an average 1-year price target for UNH of $626 , with forecasts ranging from
a
low of
$580 to a high of $675 .
UNH Lowest Price Target
Wall Street Target
580 USD
10.54%
UNH Average Price Target
Wall Street Target
626 USD
19.26%
UNH Highest Price Target
Wall Street Target
675 USD
28.64%
4. DIVIDEND
ANALYSIS
0.41%
DIVIDEND YIELD
2.1 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
UnitedHealth Group Incorporated
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
439 K USD 1
6-9 MONTHS
2.49 M USD 2
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
512 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Humana, UnitedHealth, Other Insurers Jump On Medicare Advantage Payment Hike
The Trump administration said it will raise Medicare Advantage payments sharply, good news for Humana, UnitedHealth and other health insurers. The post Humana, UnitedHealth, Other Insurers Jump On Medicare Advantage Payment Hike appeared first on Investor's Business Daily.
investors.com
- 1 week ago
Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
zacks.com
- 1 week ago
UNH Announcement: UnitedHealth Group Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices.
globenewswire.com
- 2 weeks ago
3 HMO Stocks to Watch Amid Nurse Shortages, High Tech Costs
The Medical-HMO industry rides on steady premium flows resulting from a growing customer base and contract wins. However, industry headwinds like elevated technology costs and workforce shortages remain concerns.
zacks.com
- 2 weeks ago
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zacks.com
- 2 weeks ago
Final Trades: Kinsale Capital, PG&E Corp and UnitedHealth
The Investment Committee give you their top stocks to watch for the second half.
youtube.com
- 2 weeks ago
Dogs Of The Dow Chase April's 'Safer' Buy
Verizon is the only Dow Dog currently meeting the ideal of annual dividends from $1K invested exceeding its single share price. Analysts forecast net gains of 13.06% to 37.60% for the top-ten Dow Dogs by April 2026, with NVIDIA leading. The five lowest-priced Dow Dogs are expected to deliver 39.38% more gain than the general top ten by March 2026.
seekingalpha.com
- 2 weeks ago
UNH Announcement: UnitedHealth Group Investors Are Encouraged to Contact The Rosen Law Firm About Ongoing Investigation of Breaches of Fiduciary Duties by the Directors and Officers – UNH
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices.
globenewswire.com
- 2 weeks ago
Why Johnson & Johnson (JNJ), United Health (UNH) And Procter & Gamble (PG) Are Holding the S&P 500 From Dropping More
As President Trump's April 2nd “Liberation Day” approaches, the stock market has been selling off due to uncertainties on the impact of the tariff policy implementation intended to even out the presently skewed international playing field.
247wallst.com
- 2 weeks ago
ROSEN, TRUSTED INVESTOR COUNSEL, Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of UnitedHealth Group Incorporated – UNH
NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE:UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices. If you currently own shares of UnitedHealth stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=25195for more information.
accessnewswire.com
- 3 weeks ago
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of UnitedHealth Group Incorporated - UNH
NEW YORK , March 29, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices. If you currently own shares of UnitedHealth stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=25195 for more information.
prnewswire.com
- 3 weeks ago
UnitedHealth Group: A Discounted Dividend Growth Beast To Buy Now
UnitedHealth Group continues to deliver sector-crushing dividend growth to its shareholders. The company's revenue and adjusted diluted EPS climbed higher in the fourth quarter. UnitedHealth Group maintains strong financials.
seekingalpha.com
- 3 weeks ago
8. Profile
Summary
UnitedHealth Group Incorporated UNH
COUNTRY
US
INDUSTRY
Medical - Healthcare Plans
MARKET CAP
$ 480 B
Dividend Yield
0.41%
Description
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Contact
UnitedHealth Group Center, Minnetonka, MN, 55343
https://www.unitedhealthgroup.com
IPO
Date
Oct. 17, 1984
Employees
400000
Officers
Mr. James T. Barry Jr.
Director of Sales for Western Pennsylvania
Ms. Jennifer Mound Smoter
Senior Vice President & Chief Communications Officer
Mr. Christopher R. Zaetta
Executive Vice President, Chief Legal Officer & Corporate Secretary
Mr. Thomas Edward Roos
Senior Vice President & Chief Accounting Officer
Sir Andrew Philip Witty
Chief Executive Officer & Non-Independent Director
Mr. Zachary William Sopcak
Senior Vice President of Capital Markets Communications & Investor Relations
Mr. Terry Clark
Executive Vice President & Chief Marketing Officer
Mr. John F. Rex
President & Chief Financial Officer
Mr. Sandeep Dadlani
Executive Vice President and Chief Digital & Technology Officer
Mr. Rupert Bondy
Senior Counsel & Executive Vice President of Governance, Compliance and Security